Ro 491-7523/f19    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
206脆弱X症候群3

206. 脆弱X症候群 [臨床試験数:98,薬物数:73(DrugBank:27),標的遺伝子数:46,標的パスウェイ数:57
Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 98 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2011-004349-42-ES
(EUCTR)
16/08/201221/05/2012A study of the efficacy and safety of RO4917523 in patients with Fragile X SyndromeA randomized, double-blind, 12- week, parallel group, placebo-controlled study of the efficacy and safety of RO4917523 in patients with Fragile X Syndrome. Fragile X Syndrome (FXS)
MedDRA version: 14.1;Level: LLT;Classification code 10025463;Term: Major depressive disorder, single episode;System Organ Class: 10037175 - Psychiatric disorders;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
Product Name: mGlu5 antagonist
Product Code: Ro 491-7523/F18
Other descriptive name: mGlu5 antagonist
Product Name: mGlu5 antagonist
Product Code: Ro 491-7523/F19
Other descriptive name: mGlu5 antagonist
F. Hoffmann-La Roche Ltd.NULLNot RecruitingFemale: yes
Male: yes
180France;United States;Mexico;Canada;Argentina;Spain;Peru;Chile;United Kingdom;Sweden
2EUCTR2011-004349-42-GB
(EUCTR)
16/07/201225/04/2012A study of the efficacy and safety of RO4917523 in patients with Fragile X SyndromeA randomized, double-blind, 12- week, parallel group, placebo-controlled study of the efficacy and safety of RO4917523 in patients with Fragile X Syndrome. Fragile X Syndrome (FXS)
MedDRA version: 14.1;Level: LLT;Classification code 10025463;Term: Major depressive disorder, single episode;System Organ Class: 100000004873;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
Product Name: mGlu5 antagonist
Product Code: Ro 491-7523/F18
Other descriptive name: mGlu5 antagonist
Product Name: mGlu5 antagonist
Product Code: Ro 491-7523/F19
Other descriptive name: mGlu5 antagonist
F. Hoffmann-La Roche Ltd.NULLNot RecruitingFemale: yes
Male: yes
180Phase 2United States;France;Mexico;Canada;Argentina;Spain;Peru;Chile;United Kingdom;Sweden
3EUCTR2011-004349-42-SE
(EUCTR)
29/06/201202/05/2012A study of the efficacy and safety of RO4917523 in patients with Fragile X SyndromeA randomized, double-blind, 12- week, parallel group, placebo-controlled study of the efficacy and safety of RO4917523 in patients with Fragile X Syndrome. Fragile X Syndrome (FXS)
MedDRA version: 14.1;Level: LLT;Classification code 10025463;Term: Major depressive disorder, single episode;System Organ Class: 100000004873;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
Product Name: mGlu5 antagonist
Product Code: Ro 491-7523/F18
Other descriptive name: mGlu5 antagonist
Product Name: mGlu5 antagonist
Product Code: Ro 491-7523/F19
Other descriptive name: mGlu5 antagonist
F. Hoffmann-La Roche Ltd.NULLNot RecruitingFemale: yes
Male: yes
180France;United States;Mexico;Canada;Argentina;Spain;Peru;Chile;United Kingdom;Sweden